Research Information System
CNS NEUROSCIENCE & THERAPEUTICS, vol.19, no.4, pp.222-228, 2013 (SCI-Expanded)
Aims Prior studies have demonstrated the involvement of leptin and cannabinoids in food intake and metabolism. However, the interaction between leptin and cannabinoids in epilepsy has not been studied. This study elucidated the relationship between leptin and cannabinoids in penicillin-induced epileptiform activity in rats. Methods The CB1 receptor agonist, arachidonyl-2-chloroethylamide (ACEA), at doses of 2.5 and 7.5g, the CB1 receptor antagonist, [N-(piperidine-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3 carboxamide] (AM-251), at doses of 0.125 and 0.25g, and leptin, at the dose of 1g, were administered intracerebroventricularly (i.c.v.) 30min after intracortical penicillin (i.c.) application. Results Leptin caused proconvulsant activity in all groups. The administration of AM-251, at a dose of 0.25g, increased the frequency of penicillin-induced epileptiform activity by producing status epilepticus-like activity, whereas AM-251, at a dose of 0.125g, was not effective when applied alone. ACEA, at a dose of 7.5g, decreased the frequency of epileptiform activity. Leptin reversed the anticonvulsant activity of ACEA and enhanced the proconvulsant activity of AM-251. Conclusions This study provides electrophysiological evidence that the proconvulsant activity of leptin is mediated, at least in part, by inhibition of cannabinoids in the experimental model of epilepsy.